1. Home
  2. BCYC vs ATGL Comparison

BCYC vs ATGL Comparison

Compare BCYC & ATGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • ATGL
  • Stock Information
  • Founded
  • BCYC 2009
  • ATGL 2017
  • Country
  • BCYC United Kingdom
  • ATGL Hong Kong
  • Employees
  • BCYC N/A
  • ATGL N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • ATGL
  • Sector
  • BCYC Health Care
  • ATGL
  • Exchange
  • BCYC Nasdaq
  • ATGL Nasdaq
  • Market Cap
  • BCYC 511.4M
  • ATGL 409.9M
  • IPO Year
  • BCYC 2019
  • ATGL 2023
  • Fundamental
  • Price
  • BCYC $7.39
  • ATGL $28.42
  • Analyst Decision
  • BCYC Buy
  • ATGL
  • Analyst Count
  • BCYC 8
  • ATGL 0
  • Target Price
  • BCYC $29.14
  • ATGL N/A
  • AVG Volume (30 Days)
  • BCYC 438.9K
  • ATGL 11.6K
  • Earning Date
  • BCYC 05-01-2025
  • ATGL 12-31-2024
  • Dividend Yield
  • BCYC N/A
  • ATGL N/A
  • EPS Growth
  • BCYC N/A
  • ATGL N/A
  • EPS
  • BCYC N/A
  • ATGL N/A
  • Revenue
  • BCYC $35,275,000.00
  • ATGL $1,590,148.00
  • Revenue This Year
  • BCYC N/A
  • ATGL N/A
  • Revenue Next Year
  • BCYC $0.27
  • ATGL N/A
  • P/E Ratio
  • BCYC N/A
  • ATGL N/A
  • Revenue Growth
  • BCYC 30.76
  • ATGL 42.17
  • 52 Week Low
  • BCYC $6.10
  • ATGL $1.15
  • 52 Week High
  • BCYC $28.67
  • ATGL $57.32
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 40.27
  • ATGL 47.17
  • Support Level
  • BCYC $6.10
  • ATGL $29.01
  • Resistance Level
  • BCYC $8.00
  • ATGL $34.50
  • Average True Range (ATR)
  • BCYC 0.61
  • ATGL 2.76
  • MACD
  • BCYC 0.14
  • ATGL -0.42
  • Stochastic Oscillator
  • BCYC 46.07
  • ATGL 43.41

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About ATGL Alpha Technology Group Limited

Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.

Share on Social Networks: